Published in Law and Health Weekly, October 22nd, 2005
In this connection, the Danish Medicines Agency would like to draw doctors' and patients' attention to the introduction of increasingly stringent requirements for authorization of substitution and thereby pharmacies' possibility for automatic substitution. The more stringent requirements are intended to ensure that epilepsy patients can confidently change between different copies of their medicine.
Generic medicine is often authorized by means of demonstration of a so-called 'bioequivalence',...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.